148 related articles for article (PubMed ID: 14870981)
1. DNA, the immune system, and atopic disease.
Hussain I; Kline JN
J Investig Dermatol Symp Proc; 2004 Jan; 9(1):23-8. PubMed ID: 14870981
[TBL] [Abstract][Full Text] [Related]
2. CpG oligodeoxynucleotides in asthma.
Hussain I; Kline JN
Curr Opin Investig Drugs; 2001 Jul; 2(7):914-8. PubMed ID: 11757790
[TBL] [Abstract][Full Text] [Related]
3. CpG oligodeoxynucleotides: a novel therapeutic approach for atopic disorders.
Hussain I; Kline JN
Curr Drug Targets Inflamm Allergy; 2003 Sep; 2(3):199-205. PubMed ID: 14561154
[TBL] [Abstract][Full Text] [Related]
4. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
Fonseca DE; Kline JN
Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of asthma using CpG oligodeoxynucleotides.
Kline JN
Immunol Res; 2007; 39(1-3):279-86. PubMed ID: 17917072
[TBL] [Abstract][Full Text] [Related]
6. CpG DNA: immunomodulation and remodelling of the asthmatic airway.
Jain VV; Kline JN
Expert Opin Biol Ther; 2004 Sep; 4(9):1533-40. PubMed ID: 15335319
[TBL] [Abstract][Full Text] [Related]
7. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.
Kline JN; Waldschmidt TJ; Businga TR; Lemish JE; Weinstock JV; Thorne PS; Krieg AM
J Immunol; 1998 Mar; 160(6):2555-9. PubMed ID: 9510150
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma.
Givens BE; Geary SM; Salem AK
Immunotherapy; 2018 Jun; 10(7):595-604. PubMed ID: 29569508
[TBL] [Abstract][Full Text] [Related]
9. CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma.
Gupta GK; Agrawal DK
BioDrugs; 2010 Aug; 24(4):225-35. PubMed ID: 20623989
[TBL] [Abstract][Full Text] [Related]
10. Eat dirt: CpG DNA and immunomodulation of asthma.
Kline JN
Proc Am Thorac Soc; 2007 Jul; 4(3):283-8. PubMed ID: 17607014
[TBL] [Abstract][Full Text] [Related]
11. Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors.
Parronchi P; Brugnolo F; Annunziato F; Manuelli C; Sampognaro S; Mavilia C; Romagnani S; Maggi E
J Immunol; 1999 Dec; 163(11):5946-53. PubMed ID: 10570281
[TBL] [Abstract][Full Text] [Related]
12. Antioxidants may increase the probability of developing allergic diseases and asthma.
Murr C; Schroecksnadel K; Winkler C; Ledochowski M; Fuchs D
Med Hypotheses; 2005; 64(5):973-7. PubMed ID: 15780494
[TBL] [Abstract][Full Text] [Related]
13. Immunocompetence and allergy.
McGeady SJ
Pediatrics; 2004 Apr; 113(4 Suppl):1107-13. PubMed ID: 15060206
[TBL] [Abstract][Full Text] [Related]
14. Allergy, parasites, and the hygiene hypothesis.
Yazdanbakhsh M; Kremsner PG; van Ree R
Science; 2002 Apr; 296(5567):490-4. PubMed ID: 11964470
[TBL] [Abstract][Full Text] [Related]
15. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides.
Sur S; Wild JS; Choudhury BK; Sur N; Alam R; Klinman DM
J Immunol; 1999 May; 162(10):6284-93. PubMed ID: 10229876
[TBL] [Abstract][Full Text] [Related]
16. Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN.
Kim YS; Kim Y; Lee KJ; Kwon HJ; Kim DS; Kim TY
Int Arch Allergy Immunol; 2007; 144(4):315-24. PubMed ID: 17671391
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of atopy in children with type 1 diabetes mellitus, hepatitis B virus carriers, and healthy children: role of T helper 1 (Th1)-type immune response.
Cakir M; Akcay S; Karakas T; Gedik Y; Okten A; Orhan F
Allergy Asthma Proc; 2008; 29(2):166-70. PubMed ID: 18430314
[TBL] [Abstract][Full Text] [Related]
18. Atopic disorders and parasitic infections.
Reddy A; Fried B
Adv Parasitol; 2008; 66():149-91. PubMed ID: 18486690
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulatory sequence CpG elicits Th1-type immune responses in inflammatory skin lesions in an atopic dermatitis murine model.
Wang G; Fyhrquist-Vanni N; Wolff H; Dieu-Nosjean MC; Kemeny L; Homey B; Lauerma AI; Alenius H
Int Arch Allergy Immunol; 2008; 147(1):41-51. PubMed ID: 18446052
[TBL] [Abstract][Full Text] [Related]
20. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.
Obermeier F; Dunger N; Deml L; Herfarth H; Schölmerich J; Falk W
Eur J Immunol; 2002 Jul; 32(7):2084-92. PubMed ID: 12115630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
